Skip to Content

VYN 20 (Vyndaqel tafamidis meglumine 20 mg)

Generic Name: tafamidis

Pill with imprint VYN 20 is Yellow, Capsule-shape and has been identified as Vyndaqel tafamidis meglumine 20 mg. It is supplied by Pfizer Inc..

Vyndaqel is used in the treatment of amyloid cardiomyopathy and belongs to the drug class transthyretin stabilizers. Vyndaqel tafamidis meglumine 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for VYN 20

Vyndaqel

Generic Name
tafamidis
Imprint
VYN 20
Strength
tafamidis meglumine 20 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Transthyretin stabilizers
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-1975

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.